3,685
Views
76
CrossRef citations to date
0
Altmetric
Review

Treatment of central sensitization in patients with chronic pain: time for change?

, , , , , , , & show all
Pages 1961-1970 | Received 20 May 2019, Accepted 19 Jul 2019, Published online: 29 Jul 2019

References

  • Andersson HI, Ejlertsson G, Leden I, et al. Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization. Clin J Pain. 1993;9(3):174–182.
  • Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287–333.
  • Vos T, Barber RM, Bell B, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800.
  • Andersson GB. Epidemiological features of chronic low-back pain. Lancet. 1999;354(9178):581–585.
  • Waddell G, Burton AK. Occupational health guidelines for the management of low back pain at work: evidence review. Occup Med (Lond). 2001;51(2):124–135.
  • Torrance N, Elliott AM, Lee AJ, et al. Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study. Eur J Pain. 2010;14(4):380–386.
  • McBeth J, Symmons DP, Silman AJ, et al. Musculoskeletal pain is associated with a long-term increased risk of cancer and cardiovascular-related mortality. Rheumatology (Oxford). 2009;48(1):74–77.
  • Goodson NJ, Smith BH, Hocking LJ, et al. Cardiovascular risk factors associated with the metabolic syndrome are more prevalent in people reporting chronic pain: results from a cross-sectional general population study. Pain. 2013;154(9):1595–1602.
  • Merskey H,BNE. IASP Task Force on Taxonomy. Part III: pain Terms, A Current List with Definitions and Notes on Usage Classification of Chronic Pain. 2nd ed. Seattle, USA: International Association of the Study of Pain (IASP); 1994. Available from www.iasp-pain.org/AM/Template.cfm?Section=Pain_Defi…isplay.cfm&ContentID=1728#Neuropathicpain
  • Nijs J, Torres-Cueco R, van Wilgen CP, et al. Applying modern pain neuroscience in clinical practice: criteria for the classification of central sensitization pain. Pain Physician. 2014;17(5):447–457.
  • Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630–1635.
  • Hansson P. Neuropathic pain: clinical characteristics and diagnostic workup. Eur J Pain. 2002;6(Suppl A):47–50.
  • Max MB. Clarifying the definition of neuropathic pain. Pain. 2002;96(3): 406–407. author reply 407-8.
  • Backonja MM. Defining neuropathic pain. Anesth Analg. 2003;97(3):785–790.
  • IASP. I.A.f.t.S.o.P. IASP Terminology. IASP Terminology 2017. [2017 Dec 14; cited 2019 Mar 28]. Available from: https://www.iasp-pain.org/terminology?navItemNumber=576#Centralsensitization
  • Nijs J, Goubert D, Ickmans K. Recognition and treatment of central sensitization in chronic pain patients: not limited to specialized care. J Orthop Sports Phys Ther. 2016;46(12):1024–1028.
  • Nijs J, Meeus M, Van Oosterwijck J, et al. Treatment of central sensitization in patients with ‘unexplained’ chronic pain: what options do we have? Expert Opin Pharmacother. 2011;12(7):1087–1098.
  • van Den Broeke EN. Central sensitization and pain hypersensitivity: some critical considerations. F1000Res. 2018;7:1325.
  • Nijs J, Malfliet A, Ickmans K, et al. Treatment of central sensitization in patients with ‘unexplained’ chronic pain: an update. Expert Opin Pharmacother. 2014;15(12):1671–1683.
  • Kosek E, Cohen M, Baron R, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382–1386.
  • Van Oosterwijck J, Meeus M, Paul L, et al. Pain physiology education improves health status and endogenous pain inhibition in Fibromyalgia: a double-blind randomized controlled trial. Clin J Pain. 2013;29:873–882.
  • Jull G, Sterling M, Kenardy J, et al. Does the presence of sensory hypersensitivity influence outcomes of physical rehabilitation for chronic whiplash?–A preliminary RCT. Pain. 2007;129(1–2):28–34.
  • Michaleff ZA, Maher CG, Jull G, et al. A randomised clinical trial of a comprehensive exercise program for chronic whiplash: trial protocol. BMC Musculoskelet Disord. 2009;10:149.
  • Beckwee D, De Hertogh W, Lievens P, et al. Effect of tens on pain in relation to central sensitization in patients with osteoarthritis of the knee: study protocol of a randomized controlled trial. Trials. 2012;13:21.
  • Schabrun SM, Jones E, Elgueta Cancino EL, et al. Targeting chronic recurrent low back pain from the top-down and the bottom-up: a combined transcranial direct current stimulation and peripheral electrical stimulation intervention. Brain Stimul. 2014;7:451–459.
  • Bialosky JE, George SZ, Horn ME, et al. Spinal manipulative therapy-specific changes in pain sensitivity in individuals with low back pain (NCT01168999). J Pain. 2014;15(2):136–148.
  • Malfliet A, Kregel J, Coppieters I, et al. Effect of pain neuroscience education combined with cognition-targeted motor control training on chronic spinal pain: a randomized clinical trial. JAMA Neurol. 2018;75(7):808–817.
  • Lluch E, Duenas L, Falla D, et al. Preoperative pain neuroscience education combined with knee joint mobilization for knee osteoarthritis: a randomized controlled trial. Clin J Pain. 2018;34(1):44–52.
  • Nijs J, Van Houdenhove B, Oostendorp RA. Recognition of central sensitization in patients with musculoskeletal pain: application of pain neurophysiology in manual therapy practice. Man Ther. 2010;15(2):135–141.
  • Staud R, Craggs JG, Perlstein WM, et al. Brain activity associated with slow temporal summation of C-fiber evoked pain in fibromyalgia patients and healthy controls. Eur J Pain. 2008;12(8):1078–1089.
  • Craggs JG, Staud R, Robinson ME, et al. Effective connectivity among brain regions associated with slow temporal summation of C-fiber-evoked pain in fibromyalgia patients and healthy controls. J Pain. 2012;13(4):390–400.
  • Vase L, Nikolajsen L, Christensen B, et al. Cognitive-emotional sensitization contributes to wind-up-like pain in phantom limb pain patients. Pain. 2011;152(1):157–162.
  • Kamper SJ, Maher CG, Hush JM, et al. Relationship between pressure pain thresholds and pain ratings in patients with whiplash-associated disorders. Clin J Pain. 2011;27(6):495–501.
  • Brosschot JF. Cognitive-emotional sensitization and somatic health complaints. Scand J Psychol. 2002;43(2):113–121.
  • Suzuki R, Dickenson A. Spinal and supraspinal contributions to central sensitization in peripheral neuropathy. Neurosignals. 2005;14(4):175–181.
  • Arendt-Nielsen L, Nie H, Laursen MB, et al. Sensitization in patients with painful knee osteoarthritis. Pain. 2010;149(3):573–581.
  • Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010;23(5):611–615.
  • Krishnan GP, Gonzalez OC, Bazhenov M. Origin of slow spontaneous resting-state neuronal fluctuations in brain networks. Proc Natl Acad Sci U S A. 2018;115(26):6858–6863.
  • Loggia ML, Chonde DB, Akeju O, et al. Evidence for brain glial activation in chronic pain patients. Brain. 2015;138(Pt 3):604–615.
  • Albrecht DS, Forsberg A, Sandstrom A, et al. Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation. Brain Behav Immun. 2019;75:72–83.
  • Albrecht DS, Ahmed SU, Kettner NW, et al. Neuroinflammation of the spinal cord and nerve roots in chronic radicular pain patients. Pain. 2018;159(5):968–977.
  • Smith PA. BDNF: no gain without pain? Neuroscience. 2014;283:107–123.
  • Ferrini F, De Koninck Y. Microglia control neuronal network excitability via BDNF signalling. Neural Plast. 2013;2013:429815.
  • Gao YJ, Ji RR. Activation of JNK pathway in persistent pain. Neurosci Lett. 2008;437(3):180–183.
  • Delpech JC, Madore C, Nadjar A, et al. Microglia in neuronal plasticity: influence of stress. Neuropharmacology. 2015;96(Pt A):19–28.
  • Ji RR, Kohno T, Moore KA, et al. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci. 2003;26(12):696–705.
  • Zhou LJ, Yang T, Wei X, et al. Brain-derived neurotrophic factor contributes to spinal long-term potentiation and mechanical hypersensitivity by activation of spinal microglia in rat. Brain Behav Immun. 2011;25(2):322–334.
  • Zhuo M. A synaptic model for pain: long-term potentiation in the anterior cingulate cortex. Mol Cells. 2007;23(3):259–271.
  • Dong Y, Benveniste EN. Immune function of astrocytes. Glia. 2001;36(2):180–190.
  • Raghavendra V, Tanga FY, DeLeo JA. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci. 2004;20(2):467–473.
  • Ji RR, Nackley A, Huh Y, et al. Neuroinflammation and Central Sensitization in Chronic and Widespread Pain. Anesthesiology. 2018;129(2):343–366.
  • Van Oosterwijck J, Nijs J, Meeus M, et al. Evidence for central sensitization in chronic whiplash: A systematic literature review. Eur J Pain. 2013;17(3):299–312.
  • Arendt-Nielsen L, Graven-Nielsen T. Central sensitization in fibromyalgia and other musculoskeletal disorders. Curr Pain Headache Rep. 2003;7(5):355–361.
  • Lluch E, Torres R, Nijs J, et al. Evidence for central sensitization in patients with osteoarthritis pain: a systematic literature review. Eur J Pain. 2014;18(10):1367–1375.
  • Burstein R, Levy D, Jakubowski M. Effects of sensitization of trigeminovascular neurons to triptan therapy during migraine. Rev Neurol (Paris). 2005;161(6–7):658–660.
  • Chalaye P, Goffaux P, Bourgault P, et al. Comparing Pain Modulation and Autonomic Responses in Fibromyalgia and Irritable Bowel Syndrome Patients. Clin J Pain. 2012;28(6):519–526.
  • Nijs J, Meeus M, Van Oosterwijck J, et al. In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome. Eur J Clin Invest. 2012;42(2):203–212.
  • Pas R, Ickmans K, Van Oosterwijck S, et al. Hyperexcitability of the central nervous system in children with chronic pain: a systematic review. Pain Med. 2018;19:2504–2514.
  • Malfliet A, Kregel J, Cagnie B, et al. Lack of evidence for central sensitization in idiopathic, non-traumatic neck pain: a systematic review. Pain Physician. 2015;18(3):223–236.
  • Plinsinga ML, Brink MS, Vicenzino B, et al. Evidence of nervous system sensitization in commonly presenting and persistent painful Tendinopathies: a systematic review. J Orthop Sports Phys Ther. 2015;45(11):864–875.
  • Sanchis MN, Lluch E, Nijs J, et al. The role of central sensitization in shoulder pain: A systematic literature review. Semin Arthritis Rheum. 2015;44(6):710–716.
  • Meeus M, Vervisch S, De Clerck LS, et al. Central sensitization in patients with rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum. 2012;41(4):556–567.
  • Nijs J, Leysen L, Adriaenssens N, et al. Pain following cancer treatment: guidelines for the clinical classification of predominant neuropathic, nociceptive and central sensitization pain. Acta Oncol. 2016;55(6):659–663.
  • Coombes BK, Bisset L, Vicenzino B. Thermal hyperalgesia distinguishes those with severe pain and disability in unilateral lateral epicondylalgia. Clin J Pain. 2012;28(7):595–601.
  • Coombes BK, Bisset L, Vicenzino B. Cold hyperalgesia associated with poorer prognosis in lateral epicondylalgia: a 1-year prognostic study of physical and psychological factors. Clin J Pain. 2015;31(1):30–35.
  • Sterling M, Jull G, Kenardy J. Physical and psychological factors maintain long-term predictive capacity post-whiplash injury. Pain. 2006;122(1–2):102–108.
  • Kim SH, Yoon KB, Yoon DM, et al. Influence of centrally mediated symptoms on postoperative pain in Osteoarthritis patients undergoing total knee arthroplasty: a prospective observational evaluation. Pain Pract. 2015;15(6):E46–53.
  • Aguilar Ferrandiz ME, Nijs J, Gidron Y, et al. Auto-targeted neurostimulation is not superior to placebo in chronic low back pain: a fourfold blind randomized clinical trial. Pain Physician. 2016;19(5):E707–19.
  • Gwilym SE, Oag HC, Tracey I, et al. Evidence that central sensitisation is present in patients with shoulder impingement syndrome and influences the outcome after surgery. J Bone Joint Surg Br. 2011;93(4):498–502.
  • Valencia C, Fillingim RB, Bishop M, et al. Investigation of central pain processing in postoperative shoulder pain and disability. Clin J Pain. 2014;30(9):775–786.
  • Bennett EE, Walsh KM, Thompson NR, et al. Central sensitization inventory as a predictor of worse quality of life measures and increased length of stay following spinal fusion. World Neurosurg. 2017;104:594–600.
  • Yarnitsky D, Crispel Y, Eisenberg E, et al. Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain. 2008;138(1):22–28.
  • Louw A, Diener I, Butler DS, et al. The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil. 2011;92(12):2041–2056.
  • Nijs J, Paul van Wilgen C, Van Oosterwijck J, et al. How to explain central sensitization to patients with ‘unexplained’ chronic musculoskeletal pain: practice guidelines. Man Ther. 2011;16(5):413–418.
  • Van Oosterwijck J, Nijs J, Meeus M, et al. Pain neurophysiology education improves cognitions, pain thresholds, and movement performance in people with chronic whiplash: a pilot study. J Rehabil Res Dev. 2011;48(1):43–58.
  • Moseley GL. Evidence for a direct relationship between cognitive and physical change during an education intervention in people with chronic low back pain. Eur J Pain. 2004;8(1):39–45.
  • Moseley GL. Widespread brain activity during an abdominal task markedly reduced after pain physiology education: fMRI evaluation of a single patient with chronic low back pain. Aust J Physiother. 2005;51(1):49–52.
  • Moseley GL. Joining forces – combining cognition-targeted motor control training with group or individual pain physiology education: a successful treatment for chronic low back pain. J Man Manip Ther. 2003;11:88–94.
  • Moseley GL, Nicholas MK, Hodges PW. A randomized controlled trial of intensive neurophysiology education in chronic low back pain. Clin J Pain. 2004;20(5):324–330.
  • Moseley GL. Combined physiotherapy and education is efficacious for chronic low back pain. Aust J Physiother. 2002;48(4):297–302.
  • Louw A, Zimney K, Puentedura EJ, et al. The efficacy of pain neuroscience education on musculoskeletal pain: A systematic review of the literature. Physiother Theory Pract. 2016;32(5):332–355.
  • Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2–15.
  • Lluch Girbes E, Meeus M, Baert I, et al. Balancing “hands-on” with “hands-off” physical therapy interventions for the treatment of central sensitization pain in osteoarthritis. Man Ther. 2015;20(2):349–352.
  • Arendt-Nielsen L. Central sensitization in humans: assessment and pharmacology. Handb Exp Pharmacol. 2015;227:79–102.
  • Arendt-Nielsen L, Morlion B, Perrot S, et al. Assessment and manifestation of central sensitisation across different chronic pain conditions. Eur J Pain. 2018;22(2):216–241.
  • Busse JW, Wang L, Kamaleldin M, et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. Jama. 2018;320(23):2448–2460.
  • Crofford LJ. Adverse effects of chronic opioid therapy for chronic musculoskeletal pain. Nat Rev Rheumatol. 2010;6(4):191–197.
  • Compton P, Kehoe P, Sinha K, et al. Gabapentin improves cold-pressor pain responses in methadone-maintained patients. Drug Alcohol Depend. 2010;109(1–3):213–219.
  • Vanderah TW, Ossipov MH, Lai J, et al. Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain. 2001;92(1–2):5–9.
  • Clauw DJ, Essex MN, Pitman V, et al. Reframing chronic pain as a disease, not a symptom: rationale and implications for pain management. Postgrad Med. 2019;131(3):185–198.
  • Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci. 1984;7:309–338.
  • Le Bars D, Dickenson AH, Rivot JP, et al. [Are bulbo-spinal serotonergic systems involved in the detection of nociceptive messages? (author’s transl)]. J Physiol (Paris). 1981;77(2–3):463–471.
  • Cortes-Altamirano JL, Olmos-Hernandez A, Jaime HB, et al. Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 Receptors and their role in the modulation of pain response in the central nervous system. Curr Neuropharmacol. 2018;16(2):210–221.
  • Millan MJ. Descending control of pain. Prog Neurobiol. 2002;66(6):355–474.
  • Dworkin RH, O’Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132(3):237–251.
  • Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014;1:Cd007115.
  • Chappell AS, Ossanna MJ, Liu-Seifert H, et al. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain. 2009;146(3):253–260.
  • Pergolizzi JV Jr., Raffa RB, Taylor R Jr., et al. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain Pract. 2013;13(3):239–252.
  • Skljarevski V, Desaiah D, Liu-Seifert H, et al. Efficacy and safety of duloxetine in patients with chronic low back pain. Spine (Phila Pa 1976). 2010;35(13):E578–85.
  • Staud R, Robinson ME, Vierck CJ Jr., et al. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain. 2003;101(1–2):167–174.
  • Bannister K, Patel R, Goncalves L, et al. Diffuse noxious inhibitory controls and nerve injury: restoring an imbalance between descending monoamine inhibitions and facilitations. Pain. 2015;156(9):1803–1811.
  • Hayashida KI, Obata H. Strategies to treat chronic pain and strengthen impaired descending Noradrenergic inhibitory system. Int J Mol Sci. 2019;20(4):822.
  • Taylor BK, Westlund KN. The noradrenergic locus coeruleus as a chronic pain generator. J Neurosci Res. 2017;95(6):1336–1346.
  • Kremer M, Yalcin I, Goumon Y, et al. A dual noradrenergic mechanism for the relief of neuropathic allodynia by the antidepressant drugs Duloxetine and amitriptyline. J Neurosci. 2018;38(46):9934–9954.
  • Goldenberg DL. Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007;21(3):499–511.
  • Suarez-Roca H, Leal L, Silva JA, et al. Reduced GABA neurotransmission underlies hyperalgesia induced by repeated forced swimming stress. Behav Brain Res. 2008;189(1):159–169.
  • Quintero L, Cardenas R, Suarez-Roca H. Stress-induced hyperalgesia is associated with a reduced and delayed GABA inhibitory control that enhances post-synaptic NMDA receptor activation in the spinal cord. Pain. 2011;152(8):1909–1922.
  • Moore RA, Wiffen PJ, Derry S, et al. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2014;4:Cd007938.
  • Roussel N, Nijs J, Meeus M, et al. Central sensitization and altered central pain processing in idiopathic chronic low back pain: fact or myth? Clin J Pain. 2013;29(7):625–638.
  • Nijs J, Apeldoorn A, Hallegraeff H, et al. Low back pain: guidelines for the clinical classification of predominant neuropathic, nociceptive, or central sensitization pain. Pain Physician. 2015;18(3):E333–46.
  • Shanthanna H, Gilron I, Rajarathinam M, et al. Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2017;14(8):e1002369.
  • Atkinson JH, Slater MA, Capparelli EV, et al. A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component. Pain. 2016;157(7):1499–1507.
  • Sutherland AM, Nicholls J, Bao J, et al. Overlaps in pharmacology for the treatment of chronic pain and mental health disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87(Pt B):290–297.
  • Cooper TE, Heathcote LC, Clinch J, et al. Antidepressants for chronic non-cancer pain in children and adolescents. Cochrane Database Syst Rev. 2017;8:Cd012535.
  • Moore RA, Derry S, Aldington D, et al. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015;(7):CD008242.
  • Moore RA, Derry S, Aldington D, et al. Amitriptyline for fibromyalgia in adults. Cochrane Database Syst Rev. 2015;7:Cd011824.
  • Alviar MJ, Hale T, Dungca M. Pharmacologic interventions for treating phantom limb pain. Cochrane Database Syst Rev. 2016;10:Cd006380.
  • Nijs J, Loggia ML, Polli A, et al. Sleep disturbances and severe stress as glial activators: key targets for treating central sensitization in chronic pain patients? Expert Opin Ther Targets. 2017;21(8):817–826.
  • Landry RP, Jacobs VL, Romero-Sandoval EA, et al. Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages. Exp Neurol. 2012;234(2):340–350.
  • Mapplebeck JC, Beggs S, Salter MW. Sex differences in pain: a tale of two immune cells. Pain. 2016;157(Suppl 1):S2–6.
  • Hou Y, Xie G, Liu X, et al. Minocycline protects against lipopolysaccharide-induced cognitive impairment in mice. Psychopharmacology (Berl). 2016;233(5):905–916.
  • Jin WJ, Feng SW, Feng Z, et al. Minocycline improves postoperative cognitive impairment in aged mice by inhibiting astrocytic activation. Neuroreport. 2014;25(1):1–6.
  • Sun JS, Yang YJ, Zhang YZ, et al. Minocycline attenuates pain by inhibiting spinal microglia activation in diabetic rats. Mol Med Rep. 2015;12(2):2677–2682.
  • Vanelderen P, Van Zundert J, Kozicz T, et al. Effect of minocycline on lumbar radicular neuropathic pain: a randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator. Anesthesiology. 2015;122(2):399–406.
  • Fransen M, McConnell S, Harmer AR, et al. Exercise for osteoarthritis of the knee. Cochrane Database Syst Rev. 2015;1:Cd004376.
  • Pillastrini P, Gardenghi I, Bonetti F, et al. An updated overview of clinical guidelines for chronic low back pain management in primary care. Joint Bone Spine. 2012;79(2):176–185.
  • Varatharajan S, Ferguson B, Chrobak K, et al. Are non-invasive interventions effective for the management of headaches associated with neck pain? An update of the Bone and Joint Decade Task Force on Neck Pain and Its Associated Disorders by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur Spine J. 2016;25(7):1971–1999.
  • Nijs J, Meeus M, Cagnie B, et al. A Modern Neuroscience Approach to Chronic Spinal Pain: combining Pain Neuroscience Education With Cognition-Targeted Motor Control Training. Phys Ther. 2014;94:730–738.
  • Nijs J, Kosek E, Vanoosterwijck J, et al. Dysfunctional endogenous analgesia during exercise in patients with chronic pain: to exercise or not to exercise? Pain Physician. 2012;15(3 Suppl):ES205–13.
  • Ang DC, Chakr R, Mazzuca S, et al. Cognitive-behavioral therapy attenuates nociceptive responding in patients with fibromyalgia: a pilot study. Arthritis Care Res (Hoboken). 2010;62(5):618–623.
  • de Lange FP, Koers A, Kalkman JS, et al. Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome. Brain. 2008;131(Pt 8):2172–2180.
  • Onen SH, Alloui A, Gross A, et al. The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res. 2001;10(1):35–42.
  • Schuh-Hofer S, Wodarski R, Pfau DB, et al. One night of total sleep deprivation promotes a state of generalized hyperalgesia: a surrogate pain model to study the relationship of insomnia and pain. Pain. 2013;154(9):1613–1621.
  • Smith MT, Edwards RR, McCann UD, et al. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep. 2007;30(4):494–505.
  • Campbell CM, Buenaver LF, Finan P, et al. Sleep, pain catastrophizing, and central sensitization in Knee Osteoarthritis patients with and without Insomnia. Arthritis Care Res (Hoboken). 2015;67(10):1387–1396.
  • Curatolo M, Muller M, Ashraf A, et al. Pain hypersensitivity and spinal nociceptive hypersensitivity in chronic pain: prevalence and associated factors. Pain. 2015;156(11):2373–2382.
  • Nijs J, Mairesse O, Neu D, et al. Sleep disturbances in chronic pain: neurobiology, assessment, and treatment in physical therapist practice. Phys Ther. 2018;98(5):325–335.
  • Holton KF, Kindler LL, Jones KD. Potential dietary links to central sensitization in fibromyalgia: past reports and future directions. Rheum Dis Clin North Am. 2009;35(2):409–420.
  • Allison DJ, Thomas A, Beaudry K, et al. Targeting inflammation as a treatment modality for neuropathic pain in spinal cord injury: a randomized clinical trial. J Neuroinflammation. 2016;13(1):152.
  • Afshari K, Dehdashtian A, Haddadi NS, et al. Anti-inflammatory effects of Metformin improve the neuropathic pain and locomotor activity in spinal cord injured rats: introduction of an alternative therapy. Spinal Cord. 2018;56(11):1032–1041.
  • Liu Y, Ni Y, Zhang W, et al. Anti-nociceptive effects of caloric restriction on neuropathic pain in rats involves silent information regulator 1. Br J Anaesth. 2018;120(4):807–817.
  • Brain K, Burrows TL, Rollo ME, et al. A systematic review and meta-analysis of nutrition interventions for chronic noncancer pain. J Hum Nutr Diet. 2019;32(2):198–225.
  • Cooper L, Ryan CG, Ells LJ, et al. Weight loss interventions for adults with overweight/obesity and chronic musculoskeletal pain: a mixed methods systematic review. Obes Rev. 2018;19(7):989–1007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.